Cited by 479Amyotrophic Lateral Sclerosis ResearchGenomics, phytochemicals, and oxidative stressGenetic Neurodegenerative Diseases

Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis

Open access
Vargas, Marcelo R., Johnson, Delinda A., Sirkis, Daniel W., Messing, Albee, Johnson, Jeffrey A.·2008·The Journal of Neuroscience

Abstract

Activation of the transcription factor Nrf2 in astrocytes coordinates the upregulation of antioxidant defenses and confers protection to neighboring neurons. Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) cause familial forms of amyotrophic lateral sclerosis (ALS), a fatal disorder characterized by the progressive loss of motor neurons. Non-neuronal cells, including astrocytes, shape motor neuron survival in ALS and are a potential target to prevent motor neuron degeneration. The protective effect of Nrf2 activation in astrocytes has never been examined in a chronic model of neurodegeneration. We generated transgenic mice over-expressing Nrf2 selectively in astrocytes using the glial fibrillary acidic protein (GFAP) promoter. The toxicity of astrocytes expressing ALS-linked mutant hSOD1 to cocultured motor neurons was reversed by Nrf2 over-expression. Motor neuron protection depended on increased glutathione secretion from astrocytes. This protective effect was also observed by crossing the GFAP-Nrf2 mice with two ALS-mouse models. Over-expression of Nrf2 in astrocytes significantly delayed onset and extended survival. These findings demonstrate that Nrf2 activation in astrocytes is a viable therapeutic target to prevent chronic neurodegeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4099-08.2008

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vargas, M. R., Johnson, D. A., Sirkis, D. W., Messing, A., & Johnson, J. A.
Affiliations
  • University of Wisconsin–Madison (US)
  • University of Wisconsin System (US)
Corresponding author
Johnson, Jeffrey A.
Venue
The Journal of Neuroscience
Published
2008-12-10
Volume
28
Issue
50
Pages
13574-13581
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2009517899
Cited by
479
References
42
Citations by year
2026: 20 · 2025: 18 · 2024: 24 · 2023: 26 · 2022: 21 · 2021: 23 · 2020: 29 · 2019: 24 · 2018: 23 · 2017: 23 · 2016: 24 · 2015: 33 · 2014: 33 · 2013: 30 · 2012: 41
FWCI
18.02
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • ALS Association
  • Johns Hopkins University
  • National Institute of Neurological Disorders and Stroke (R01NS060120)
  • National Institute of Environmental Health Sciences (ES10042, R01ES010042, ES08089, R01ES008089, R29ES008089)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD003352)
  • Robert Packard Center for ALS Research, Johns Hopkins University
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords
Nrf2, astrocytes, familial ALS, SOD1 mutations, motor neuron protection, neurodegeneration, antioxidant defense, GFAP promoter, astrocyte-neuron co-culture, therapeutic target
MeSH terms
Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Astrocytes, Disease Models, Animal, Fluorescent Antibody Technique, Glutathione, Humans, Immunohistochemistry, Mice, Transgenic, Motor Neurons, Nerve Degeneration, Spinal Cord, Superoxide Dismutase, Blotting, Western, Muscle, Skeletal, Coculture Techniques, Reverse Transcriptase Polymerase Chain Reaction, NF-E2-Related Factor 2, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review